Effect of Age on Oral Contraceptive-Induced Venous Thrombosis
Open Access
- 1 July 2004
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 10 (3) , 259-263
Abstract
This study was undertaken to investigate the effect of age on oral contraceptive-induced venous thrombosis. All women seen in the University of Padua Department of Medical and Surgical Science who had had two courses of oral contraceptive therapy at different ages were included. A total of 28 subjects met these criteria. Fifteen patients had a congenital or acquired prothrombotic condition, whereas 13 women were normal subjects. The mean age at which thrombosis occurred was 33.3 and 36.3 years for women with or without a prothrombotic condition, respectively. The ages during which the women remained asymptomatic were 23.1 and 23.3 years for women with or without a predisposing defect, respectively. Thrombosis occurred, during the second course of oral contraceptive therapy, after the mean duration of 6.5 cycles or 18.4 cycles in women with or without prothrombotic defects, respectively. During the asymptomatic course, approximately the same number of women took old progestins or third-generation compounds. On the contrary, during the second period, 21 of 28 women took progestins with third-generation compounds. Age seems to plays an important role in oral contraceptive-induced venous thrombosis. In normal women, thrombosis occurred after a greater number of oral contraceptive cycles as compared with the women with prothrombotic defects. Because the majority of women took preparations that contained third-generation progestins during the second course of therapy, concomitant contributing effects of these compounds cannot be excluded.Keywords
This publication has 28 references indexed in Scilit:
- Oral Contraceptives and the Risk of Venous ThrombosisNew England Journal of Medicine, 2001
- Oral contraceptives and venous thromboembolismContraception, 1998
- Homozygous patients with APC resistance may remain paucisymptomatic or asymptomatic during oral contraceptionBlood Coagulation & Fibrinolysis, 1996
- Patients with APC Resistance Compared with Those with Other Clotting Inhibitor Deficiencies Show Later Onset of Venous Thrombosis During Oral ContraceptionClinical and Applied Thrombosis/Hemostasis, 1995
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994
- Oral contraceptives caused thrombosis in a monoovular twin with protein C deficiency, while the other, without medication, remained asymptomaticBlood Coagulation & Fibrinolysis, 1992
- The role of drugs, particularly oral contraceptives, in triggering thrombosis in congenital defects of coagulation inhibitorsBlood Coagulation & Fibrinolysis, 1991
- A Population-Based Perspective of the Hospital Incidence and Case-Fatality Rates of Deep Vein Thrombosis and Pulmonary EmbolismArchives of internal medicine (1960), 1991
- Oral contraceptives and venous thromboembolism: findings in a large prospective study.BMJ, 1986
- The post-mortem incidence of pulmonary embolism in a hospital populationBritish Journal of Surgery, 1968